Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04751968
Status:
COMPLETED
Last Update Posted:
2024-05-06
First Post:
2021-02-02
Brief Title:
BRAVA Building Resilience and Attachment in Vulnerable Adolescents
Sponsor:
Childrens Hospital of Eastern Ontario
Organization:
Childrens Hospital of Eastern Ontario
Study Overview
Official Title:
Building Resilience and Attachment in Vulnerable Adolescents BRAVA A Randomized Controlled Trial of a Brief Group Intervention for Adolescents With Mild to Moderate Suicidal Ideation and Their Caregivers
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BRAVA
Brief Summary:
The prevalence of suicidal ideation SI among adolescents in North America is high making it critical to develop evidence-based brief interventions for adolescents with SI that target healthy coping skills and relationships BRAVA is a novel brief group intervention for adolescents with mild to moderate SI and their caregivers youth are taught skills for coping and relating more effectively with others Caregivers learn about adolescent development effective parenting and the importance of connection The goal of the randomized controlled trial is to assess the efficacy of a virtually-delivered brief group intervention for adolescents with mild to moderate SI and their caregivers in reducing SI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None